Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. Q1 FY2024 earnings call
May 1, 2024 · fiscal period ended 2024-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2024-05-01
Management highlights
- First quarter 2024 revenue and adjusted EBITDA were in line with expectations. Team performing well in a tough environment with travel demand softened. Focus on growth opportunities across portfolio including locums, education, home care staffing, etc. - Travel business: Demand down in high double digits since end of 2023, weekly production down mid- to high single digits, open order rates stable, average bill rates declining. - Local or per diem business faced headwinds with double-digit sequential volume decline and mid- to high single-digit REITs decline. Focus on expanding into non-acute care settings. - Strong performance in other lines: Physician Staffing revenue up double digits YOY, Homecare up mid-single digits YOY and sequentially, Education up low double digits sequentially. - Actions taken to align cost structure: U.S. head count down over 20% since start of year, leveraging India operations for cost savings, investments in technology like Intellify, migration of legacy clients to Intellify. - Outlook for second quarter: Revenue between $330M - $340M, adjusted EBITDA $10M - $15M, goal for high single-digit adjusted EBITDA margin, focus on strategic technology investments, share repurchases, potential M&A.
Segment performance
Nurse and Allied reported revenue of $332 million, down 10% sequentially and 43% from the prior year. Travel nurse in Allied was down 11% sequentially and 48% from the prior year, with billable hours down 9% sequentially and bill rates down 2%. Local business first quarter revenue was down 36% from the prior year and 19% sequentially. Homecare Staffing was up 4% sequentially, Education was up 11%. Physician Staffing delivered $47 million in revenue, up 16% over the prior year and flat sequentially.
Guidance
- Second quarter revenue anticipated between $330 million and $340 million, adjusted EBITDA $10 million to $15 million. - Goal to achieve high single-digit adjusted EBITDA margin, expect mid-single-digit adjusted EBITDA margins near term while maintaining capacity. - Focus on putting healthy balance sheet to work through strategic technology investments, share repurchases, and potential M&A. - Goal to close on several accretive acquisitions to diversify platform, enhance value proposition, and improve margin profile.
Risks
- Market headwinds affecting travel and local business demand. - Competitive pressures impacting bill-pay spreads. - Burden charges such as health insurance, workers' comp, and professional liability that can put incremental pressure on gross margin. - Uncertainties in the travel market recovery timeline.
Q&A highlights
Q: Trevor Romeo asked about Q2 guide, demand trends for first 4 months of the year and competitive headwinds.
A: Bill Burns said Q2 not following historic patterns, driven by travel, bill rates projected to decline, John Martins added demand fell sharply but leveled off last 6 weeks.
Q: Brian Tanquilut asked about locums supply and sustainability.
A: John Martins said locums has long runway for physicians, need to attract right candidates and offer quality jobs.
Q: Albert Rice asked about gross margin pressure and competitive pressure on bill-pay spread.
A: William Burns said burden charges were a surprise, payroll tax reset higher, competitive pressure still prevalent but open order rate ticked up.
Q: A.J. Rice asked about gross margin and incremental pressure.
A: William Burns said burden charges like health insurance, workers' comp, professional liability were surprises, but majority not expected to recur.
Q: Albert Rice asked about availability of supply and expectations.
A: John Martins said expectations reset, some travelers went back to core, Marc Krug added reset on expectations, pay transparency.
Q: William Sutherland asked about Allied business growth.
A: William Burns said Allied business more resistant to decline, Marc Krug mentioned strong demand in imaging, physical therapy.
Q: Constantine Davides asked about per diem challenges.
A: John Martins said per diem parallel to nursing side, affected by acute care and skilled nursing facility changes, William Burns said local business sequentially flat.
Q: Tobey Sommer asked about competitive pressures and Intellify.
A: John Martins said competitive effects baked out, William Burns said order volume improvement from won programs, John Martins talked about Intellify's importance.
Q: Kevin Steinke asked about Intellify pipeline and local staffing commitment.
A: John Martins said Intellify pipeline robust but cycles longer, local staffing committed to finding right opportunities for strategic partnerships.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.19 | $0.17 | +9.2% | $0.84 |
| Revenue | $379.2M | $377.8M | +0.4% | $622.7M |
Transcript
May 1, 2024Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.